← Concord Medical Services Holdings Ltd
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net loss | ($265.1m) | ($43.9m) | ($259.3m) | ($352.1m) | ($404.0m) | ($522.7m) | ($769.0m) | ($531.0m) | ($652.1m) | ($379.4m) | — | |
| Net Income (Loss) Attributable to Parent | ($37.7m) |
($43.7m)
-15.86%
|
($34.2m)
+21.82%
|
($44.1m)
-29.11%
|
($47.5m)
-7.72%
|
($42.6m)
+10.35%
|
($71.0m)
-66.67%
|
($41.9m)
+40.94%
|
($42.2m)
-0.72%
|
($13.3m)
+68.57%
|
— | |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | ($52.2m) |
($79.4m)
-51.90%
|
($102.7m)
-29.36%
|
($128.8m)
-25.43%
|
($71.0m)
+44.87%
|
($41.9m)
+40.94%
|
($42.2m)
-0.72%
|
($13.3m)
+68.57%
|
— | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ($38.2m) | ($285.7m) | ($37.7m) | ($50.6m) | ($61.9m) | ($82.0m) | ($111.5m) | ($74.8m) | ($89.3m) | ($54.3m) | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | ($463k) | ($210k) | ($3.6m) | ($6.5m) | ($14.4m) | ($39.4m) | ($40.5m) | ($32.9m) | ($47.1m) | ($41.0m) | — | |
| Depreciation | $16.9m | $12.8m | $5.9m | $6.4m | $8.4m | $10.1m | $12.9m | $11.6m | $11.6m | $14.8m | $103.5m | |
| Amortization | $172k | $808k | $1.4m | — | — | — | — | — | — | — | $45.7m | |
| Amortization of Debt Issuance Costs | — | — | — | — | — | $914k | $914k | — | — | — | — | |
| Amortization of Intangible Assets | $1.6m | $957k | $605k | $1.7m | $2.4m | $4.7m | $5.0m | $5.2m | $5.0m | $5.2m | — | |
| Depreciation of property, plant and equipment (note 10) | $117.1m | $83.2m | $40.9m | $44.4m | $55.0m | $64.3m | $88.7m | $82.1m | $84.8m | $103.5m | $149.3m | |
| Amortization of intangible assets (note 13) | $10.8m | $6.2m | $4.2m | $12.0m | $15.8m | $30.2m | $34.5m | $36.7m | $36.4m | $36.1m | — | |
| Amortization of land lease payments (note 11) | — | $5.3m | $9.6m | $0 | $9.5m | $9.6m | $9.6m | $9.6m | $9.6m | $9.6m | — | |
| Deferred Income Tax Expense (Benefit) | $5.0m | $4.1m | ($1.3m) | ($3.2m) | ($2.1m) | ($1.7m) | ($9.0m) | ($2.5m) | ($2.1m) | ($1.1m) | ($7.9m) | |
| Deferred tax expense (benefit) | $22.1m | $12.7m | $7.5m | ($22.5m) | ($13.3m) | $11.3m | ($71.8m) | ($13.0m) | ($15.7m) | ($7.9m) | — | |
| Share-based Payment Arrangement, Noncash Expense | $1.2m | $1.8m | $1.6m | $3.0m | $3.2m | $2.3m | ($858k) | — | — | — | $0 | |
| Share-based Payment Arrangement, Expense | $1.2m | $1.8m | $1.6m | $3.0m | $3.2m | $2.3m | ($858k) | — | — | — | $0 | |
| Goodwill, Impairment Loss | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $22.2m | |
| Impairment of Intangible Assets, Finite-lived | $9.8m | $598k | — | $2.9m | — | — | — | — | — | — | — | |
| Equity Method Investment, Realized Gain (Loss) on Disposal | — | — | $7.0m | $0 | $1.2m | $0 | — | $5.3m | ($16k) | $5.4m | — | |
| Income (Loss) from Equity Method Investments | $89k | $223k | ($3.0m) | ($729k) | $923k | $2.9m | $2.6m | $2.9m | $1.7m | $1.9m | — | |
| Other Nonoperating Income (Expense) | $2.6m | $444k | $5.0m | $5.3m | $967k | ($192k) | ($31.4m) | ($1.5m) | ($1.3m) | ($1.1m) | — | |
| Income from equity method investments | ($616k) | ($1.5m) | $20.7m | $5.1m | ($6.0m) | ($18.2m) | ($17.6m) | ($20.8m) | ($12.7m) | ($13.0m) | — | |
| Gain on sale of partial interests in equity method investment | $0 | $0 | ($48.0m) | $0 | ($7.8m) | $0 | $0 | ($37.5m) | $120k | ($37.5m) | — | |
| Investment in equity investments without readily determinable fair value | — | — | — | $0 | $0 | ($6.4m) | $0 | ($100k) | — | — | — | |
| Cash distribution from equity method investments | $9.4m | $6.2m | $11.6m | $0 | $0 | $15.9m | $5.1m | $12.0m | $10.0m | — | — | |
| Proceeds from disposal of certain percentage of an equity method investment | — | — | — | — | — | $0 | $0 | $60.0m | — | — | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | ($1.4m) | ($6.7m) | ($7.0m) | ($513k) | $945k | $10.1m | ($93k) | ($5.1m) | ($1.6m) | ($879k) | $6.1m | |
| Accounts receivable | $9.9m | $43.4m | $48.4m | $3.6m | ($6.2m) | ($64.5m) | $644k | $36.5m | $12.0m | $6.1m | $6.1m | |
| Increase (Decrease) in Inventories | $277k | $85k | ($262k) | $262k | $2.2m | $683k | $6.8m | ($6.3m) | ($890k) | $1.8m | ($12.6m) | |
| Inventory Write-down | — | — | $248k | $128k | — | — | — | — | — | $7k | — | |
| Provision of Inventory write down | $0 | $0 | $1.7m | $890k | — | — | — | — | — | $52k | — | |
| Inventories | ($1.9m) | ($554k) | $1.8m | ($1.8m) | ($14.4m) | ($4.4m) | ($46.8m) | $44.5m | $6.5m | ($12.6m) | ($12.6m) | |
| Increase (Decrease) in Accounts Payable | $1.0m | $777k | $77k | $408k | $1.7m | $41.2m | $16.5m | $2.2m | $12.7m | ($17.5m) | ($122.3m) | |
| Accounts payable | $7.0m | $5.1m | $530k | $2.8m | $11.1m | $262.8m | $113.7m | $15.8m | $93.1m | ($122.3m) | ($122.3m) | |
| Accrued expenses and other liabilities | ($12.8m) | $11.2m | $51.9m | ($60.9m) | $15.2m | ($2.5m) | $119.1m | $70.8m | $97.5m | ($165.6m) | — | |
| Deferred revenue | $1.8m | $3.0m | $13.3m | $953k | $84.5m | ($193.5m) | $57.2m | ($41.2m) | ($3.1m) | $39.5m | — | |
| Accrued unrecognized tax benefit | $3.1m | $6.4m | $46.3m | ($16.2m) | ($28.0m) | $621k | ($6.5m) | ($15.8m) | $35k | $6.6m | — | |
| Acquisition of property, plant and equipment, construction in progress and other intangible assets included in accrued expense and other liabilities | $0 | $42.1m | — | $29.6m | $50.7m | $99.4m | $2.2m | $285.4m | — | — | — | |
| Prepayments and other current assets | ($36.5m) | ($4.2m) | ($9.9m) | $11.0m | ($82.5m) | ($30.9m) | ($130.2m) | ($149.7m) | ($335.7m) | $161.3m | — | |
| Net Cash Provided by (Used in) Operating Activities | ($78.1m) |
$4.1m
+105.26%
|
($5.6m)
-236.66%
|
($28.1m)
-399.79%
|
($35.2m)
-25.50%
|
($56.4m)
-60.14%
|
($31.4m)
+44.28%
|
($38.9m)
-23.95%
|
($54.5m)
-39.92%
|
($28.9m)
+47.04%
|
($201.8m)
-599.30%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $11.4m | $14.0m | $24.1m | $33.4m | $25.8m | $43.8m | $32.3m | $15.9m | $20.7m | $8.1m | ($91.3m) | |
| Gain (Loss) on Disposition of Property Plant Equipment | ($1.1m) | $4.9m | $685k | ($187k) | $104k | $0 | ($3k) | $9k | $79.6m | $10.3m | ($48.4m) | |
| Gain (Loss) on Investments | — | — | — | — | — | — | — | — | $999k | $0 | ($166k) | |
| Changes in fair value of short-term investments | — | — | — | — | — | — | $0 | $0 | ($7.3m) | — | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | $0 | $76.9m | $60.4m | $1.3m | ($246k) | — | — | — | — | ($10k) | |
| Acquisitions of intangible assets | ($960k) | ($749k) | ($1.8m) | ($576k) | ($1.0m) | ($19.7m) | ($818k) | ($4.2m) | ($10.2m) | ($30k) | — | |
| Net Cash Provided by (Used in) Investing Activities | ($74.8m) | ($48.1m) | ($145.5m) | ($153.9m) | ($81.8m) | ($88.8m) | ($17.2m) | ($6.7m) | ($81.3m) | $7.7m | $54.0m | |
| Cash flows from financing activities: | ||||||||||||
| Repayments of Long-term Debt | $29.0m | $13.4m | $73.4m | $36.5m | $37.1m | $32.3m | $28.6m | $1.1m | $190.6m | $62.0m | ($433.5m) | |
| Gain (Loss) on Extinguishment of Debt | — | $0 | — | — | — | — | — | — | — | — | — | |
| Proceeds from Issuance of Long-term Debt | $2.4m | $43.1m | $68.7m | $134.2m | $131.4m | $60.7m | $61.3m | $15.5m | $262.7m | $13.6m | $611.8m | |
| Proceeds from short-term bank borrowings | $497.6m | $292.8m | $726.7m | $285.5m | $740.4m | $126.1m | $217.5m | $337.7m | $504.7m | $359.2m | — | |
| Proceeds from long-term bank and other borrowings | $16.5m | $280.5m | $472.6m | $934.4m | $857.1m | $386.6m | $422.8m | $110.0m | $1.9b | $94.8m | — | |
| Borrowings from related parties (note 25) | $0 | $351.0m | $174.3m | $0 | $26.6m | $24.4m | $220.4m | $22.1m | $300.5m | $517.0m | — | |
| Repayment of short-term bank and other borrowings | ($691.3m) | ($317.9m) | ($864.3m) | ($442.8m) | ($1.0b) | ($24.7m) | ($197.6m) | ($442.9m) | ($360.3m) | ($437.1m) | — | |
| Repayment of long-term bank and other borrowings | ($201.0m) | ($87.4m) | ($504.8m) | ($253.8m) | ($241.8m) | ($206.1m) | ($197.0m) | ($7.6m) | ($1.4b) | ($433.5m) | — | |
| Payments for Repurchase of Common Stock | $4.4m | $0 | $0 | — | — | — | — | — | — | — | — | |
| Payments of Ordinary Dividends, Common Stock | $41.2m | $0 | $0 | — | — | — | — | — | — | — | — | |
| Proceeds from Issuance of Common Stock | $20.2m | $0 | $0 | — | — | — | — | — | — | — | $510.5m | |
| Dividends Payable, Current | $359k | $359k | $359k | $0 | — | — | — | — | — | — | — | |
| Proceeds from dividend | — | — | — | — | — | — | — | — | $10.0m | $3.2m | — | |
| Net cash generated from financing activities | ($131.4m) |
$194.4m
+247.98%
|
$1.2b
+518.83%
|
$513.3m
-57.34%
|
$1.1b
+121.78%
|
$642.4m
-43.56%
|
$383.1m
-40.37%
|
$257.7m
-32.74%
|
$1.1b
+344.80%
|
$197.2m
-82.79%
|
— | |
| Net Cash Provided by (Used in) Financing Activities | — | $29.9m |
$175.0m
+485.58%
|
$73.7m
-57.87%
|
$174.5m
+136.62%
|
$100.8m
-42.21%
|
$55.5m
-44.91%
|
$36.3m
-34.66%
|
$157.0m
+332.64%
|
$28.2m
-82.04%
|
$197.2m
+599.31%
|
|
| Net increase (decrease) in cash | ($295.5m) | ($91.7m) | $164.6m | ($752.4m) | $372.1m | ($287.5m) | $432k | ($68.9m) | $146.6m | $61.7m | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | ($108.1m) | $57.0m | ($45.1m) | $63k | ($9.7m) | $20.1m | $8.8m | $298.7m | |
| Cash and cash equivalents and restricted cash at beginning of the year | $758.4m | $662.2m | $826.7m | $74.3m | $446.4m | $158.9m | $159.3m | $90.4m | $237.0m | $298.7m | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $120.2m | $10.7m | $68.4m | $24.9m | $23.1m | $12.7m | $32.5m | $42.7m | $298.7m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | $166k | ($394k) | ($723k) | — | — | — | — | $12.4m | |
| Effect of foreign exchange rate changes on cash and cash equivalent and restricted cash | ($11.2m) | $157k | $459k | $1.2m | ($2.6m) | ($4.6m) | ($47.2m) | ($2.4m) | ($8.3m) | $12.4m | — | |
| Restricted cash, current portion | $518.5m | $564.0m | $422.0m | $0 | $4.7m | $1.4m | $1.1m | $32.3m | $20.8m | $921k | — | |
| Restricted cash, noncurrent portion | $50.0m | $0 | $0 | $0 | $107.5m | $138k | $0 | $0 | — | — | — | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | ($81.5m) | $13.8m | $8.7m | $9.2m | $11.3m | $21.1m | $21.1m | $21.5m | $25.8m | $26.2m | — | |
| Additional Financial Items | ||||||||||||
| Derivative, Gain (Loss) on Derivative, Net | $103k | $0 | $0 | — | — | ($6k) | $147k | $733k | $23k | — | — | |
| Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax | — | $9.1m | — | — | — | — | — | — | — | — | — | |
| Foreign Currency Transaction Gain (Loss), before Tax | $1.9m | $618k | $5.3m | $5.0m | ($9.0m) | ($3.1m) | $8.0m | $1.4m | ($2.4m) | ($1.7m) | — | |
| General and Administrative Expense | $29.7m | $36.5m | $42.4m | $45.3m | $45.2m | $54.6m | $45.1m | $46.5m | $55.4m | $30.5m | — | |
| Goodwill | — | — | $24.0m | $30.2m | $32.7m | $91.3m | $83.4m | $81.0m | $78.4m | $81.8m | $22.2m | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | ($37.7m) | — | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | ($38.2m) | ($43.9m) | ($37.7m) | ($50.6m) | ($61.9m) | ($82.0m) | ($111.5m) | ($74.8m) | ($89.3m) | ($54.3m) | — | |
| Income Tax Expense (Benefit) | $8.7m | $4.9m | $5.0m | ($5.6m) | ($5.8m) | ($1.0m) | ($10.3m) | ($3.5m) | ($2.4m) | $867k | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $26.5m | $21.8m | — | |
| Investment Income, Interest | $4.0m | $1.9m | $2.1m | $1.3m | $1.3m | $925k | $1.5m | $1.5m | $1.9m | $1.4m | — | |
| Operating Lease, Lease Income | — | — | — | $7.7m | $7.0m | $5.6m | $2.6m | $1.9m | $920k | $452k | — | |
| Proceeds from Contributed Capital | — | $3.0m | — | — | — | — | — | — | — | — | — | |
| Proceeds from Noncontrolling Interests | — | — | $218.2m | $0 | $107.3m | $62.8m | — | — | — | — | — | |
| Proceeds from (Payments to) Noncontrolling Interests | $309k | $0 | $0 | — | — | — | — | — | — | — | — | |
| Lease expense to reduce operating lease ROU | — | — | $0 | $16.7m | $23.0m | $21.7m | $19.3m | $26.7m | $22.6m | $14.8m | — | |
| Change in fair value of derivative liability | ($713k) | $0 | $0 | $0 | $0 | $39k | ($1.0m) | ($5.2m) | ($166k) | — | — | |
| (Gain) loss on disposal of long-lived assets | $7.6m | $31.4m | ($4.7m) | $1.3m | ($677k) | $0 | $3k | ($62k) | $13.1m | $2.1m | — | |
| Allowance for doubtful accounts, net | $23.4m | $14.8m | $10.6m | $24.5m | $6.1m | $2.6m | $5.4m | $64.7m | $128.2m | ($6.9m) | — | |
| Interest and consultation expenses | $0 | $125.3m | $46.2m | $53.2m | $81.4m | $73.8m | $120.4m | $165.7m | $193.2m | $152.3m | — | |
| (Gain) Loss on disposal of subsidiaries (note 4) | $0 | ($58.9m) | ($3.3m) | $0 | $14.9m | $0 | $61.5m | $638k | ($48.5m) | — | — | |
| Other non-current assets | $14.2m | $7.1m | $41.1m | $1.9m | $392k | ($175k) | ($15k) | $1.6m | ($458k) | ($958k) | — | |
| Income tax payable | ($35.0m) | ($6.5m) | ($45.7m) | $3.0m | $105k | ($858k) | $818k | $705k | $101k | $5.9m | — | |
| Operating lease liabilities | — | $0 | $0 | ($12.6m) | ($12.8m) | ($13.3m) | ($2.9m) | ($18.1m) | ($19.3m) | ($15.9m) | — | |
| Proceeds from disposal of subsidiaries | — | — | — | — | — | — | $0 | $0 | $9.1m | ($10k) | — | |
| Investment in a joint venture | — | — | — | — | — | — | $0 | $0 | ($102.0m) | — | — | |
| Proceeds from disposal of other investment | — | — | — | — | — | — | $0 | $0 | $27.7m | — | — | |
| Purchase of short - term investment | — | — | — | — | — | — | $0 | $0 | ($204.6m) | $134.6m | — | |
| Proceeds from disposal of short - term investment | — | — | — | — | — | — | $0 | $0 | $77.3m | — | — | |
| Repayment to related parties (note 25) | — | ($81.0m) | ($243.3m) | $0 | $0 | ($80.9m) | ($82.9m) | ($61.8m) | ($335.4m) | ($468.4m) | — | |
| Capital injection from a noncontrolling interests in a subsidiary | $0 | $12.8m | $0 | $0 | $110.9m | $1.5m | $0 | $300.0m | $0 | $61.0m | — | |
| Proceeds from initial public offering of Concord Healthcare Group Co., Ltd. | — | — | — | — | — | — | $0 | $0 | $510.5m | $504.2m | — | |
| Cash and cash equivalents | $189.9m | $98.2m | $404.7m | $74.3m | $334.3m | $157.4m | $158.3m | $58.1m | $216.2m | $297.8m | $237.0m | |
| Income tax paid | ($60.6m) | ($21.6m) | ($36.6m) | ($17.3m) | ($3.3m) | $0 | ($3.0m) | ($898k) | ($148k) | ($109k) | $109k |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.